BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kongtawelert P, Wudtiwai B, Shwe TH, Pothacharoen P, Phitak T. Inhibition of programmed death ligand 1 (PD-L1) expression in breast cancer cells by sesamin. Int Immunopharmacol 2020;86:106759. [PMID: 32663768 DOI: 10.1016/j.intimp.2020.106759] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Liu F, Lin Y, Li L, Chen M, Ni L, Rather MA. A Comprehensive Review on Distribution, Pharmacological Properties, and Mechanisms of Action of Sesamin. Journal of Chemistry 2022;2022:1-17. [DOI: 10.1155/2022/4236525] [Reference Citation Analysis]
2 Yang Z, Feng L, Wang M, Li Y, Bai S, Lu X, Wang H, Zhang X, Wang Y, Lin S, Tortorella MD, Li G. Sesamin Promotes Osteoporotic Fracture Healing by Activating Chondrogenesis and Angiogenesis Pathways. Nutrients 2022;14:2106. [PMID: 35631249 DOI: 10.3390/nu14102106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kumar US, Natarajan A, Massoud TF, Paulmurugan R. FN3 linked nanobubbles as a targeted contrast agent for US imaging of cancer-associated human PD-L1. J Control Release 2022:S0168-3659(22)00226-7. [PMID: 35469983 DOI: 10.1016/j.jconrel.2022.04.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sohel M, Islam MN, Hossain MA, Sultana T, Dutta A, Rahman MS, Aktar S, Islam K, Al Mamun A, Sahgal P. Pharmacological Properties to Pharmacological Insight of Sesamin in Breast Cancer Treatment: A Literature-Based Review Study. International Journal of Breast Cancer 2022;2022:1-13. [DOI: 10.1155/2022/2599689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tang N, Li L, Xie F, Lu Y, Zuo Z, Shan H, Zhang Q, Zhang L. A living cell-based fluorescent reporter for high-throughput screening of anti-tumor drugs. J Pharm Anal 2021;11:808-14. [PMID: 35028187 DOI: 10.1016/j.jpha.2021.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chun KS, Kim DH, Raut PK, Surh YJ. Anticancer natural products targeting immune checkpoint protein network. Semin Cancer Biol 2021:S1044-579X(21)00279-0. [PMID: 34838956 DOI: 10.1016/j.semcancer.2021.11.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Bailly C. Anticancer Targets and Signaling Pathways Activated by Britannin and Related Pseudoguaianolide Sesquiterpene Lactones. Biomedicines 2021;9:1325. [PMID: 34680439 DOI: 10.3390/biomedicines9101325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Pang L, Shah H, Xu Y, Qian S. Delta-5-desaturase: A novel therapeutic target for cancer management. Transl Oncol 2021;14:101207. [PMID: 34438249 DOI: 10.1016/j.tranon.2021.101207] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Zhao M, Yang X, Fu H, Chen C, Zhang Y, Wu Z, Duan Y, Sun Y. Immune/Hypoxic Tumor Microenvironment Regulation-Enhanced Photodynamic Treatment Realized by pH-Responsive Phase Transition-Targeting Nanobubbles. ACS Appl Mater Interfaces 2021;13:32763-79. [PMID: 34235912 DOI: 10.1021/acsami.1c07323] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]